Replies to post #125168 on Biotech Values

[imnot6]

Gilead - Good luck with that

Gilead seeks to capitalize on advances in cancer research that help pinpoint the way to fighting tumors, letting it repeat the company’s success in matching combinations of medicines to prolong the lives of AIDS patients.

As an umbrella theme for their portfolio, I suppose it's as good as anything - as a strategy to execute on, it strikes me as kind of like expanding from attempts to ameliorate alzheimers or ADD to finding cures for stupidity.